Cargando…
A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency
BACKGROUND: Value-based pricing (VBP) of new drugs has been suggested both as a way to control health expenditures and to maximize health benefits based on the available resources. The purpose of this work is to present a simple mathematical proof showing that prices of new drugs are set in a mathem...
Autor principal: | Gandjour, Afschin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092469/ https://www.ncbi.nlm.nih.gov/pubmed/32293433 http://dx.doi.org/10.1186/s12913-020-5055-4 |
Ejemplares similares
-
The price of curing cancer
por: Gandjour, Afschin
Publicado: (2021) -
Predictors of negotiated prices for new drugs in Germany
por: Gandjour, Afschin, et al.
Publicado: (2020) -
Value-based pricing of a COVID-19 vaccine
por: Gandjour, Afschin
Publicado: (2022) -
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment
por: Gandjour, Afschin
Publicado: (2023) -
The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
por: Tsai, Hsin-Yi, et al.
Publicado: (2022)